Virginia Schad, PharmD

Most Recent Articles by Virginia Schad, PharmD

Immune-Escape Mutations in Nucleos(t)ide Analogue-Exposed Patients May Lead to Drug-Resistance

Immune-Escape Mutations in Nucleos(t)ide Analogue-Exposed Patients May Lead to Drug-Resistance

By

Immune-escape mutations and stop-codons may develop in nucleos(t)ide analogue-exposed patients, potentially resulting in hepatitis B virus transmission to vaccinated persons.

Sofosbuvir/Ledipasvir ± Ribavirin Effectively Treats HCV After Liver, Renal Transplantation

Sofosbuvir/Ledipasvir ± Ribavirin Effectively Treats HCV After Liver, Renal Transplantation

By

Treatment of HCV with sofosbuvir/ledipasvir ± ribavirin after liver or renal transplantation is safe and effective.

Diabetes Risk Associated With Cirrhosis, Not Chronic HCV Infection, in HIV+ Patients

Diabetes Risk Associated With Cirrhosis, Not Chronic HCV Infection, in HIV+ Patients

By

Cirrhosis is associated with an increased risk for diabetes mellitus among patients living with HIV.

Transient Elastography Assessed Liver Stiffness for Estimating Chronic Hepatitis C Prognosis

Transient Elastography Assessed Liver Stiffness for Estimating Chronic Hepatitis C Prognosis

By

Liver stiffness progression rates as measured by TE are consistent with traditional fibrosis progression rates in predicting time to cirrhosis.

DAA Therapy Highly Efficacious for HCV Treatment in Older Adults

DAA Therapy Highly Efficacious for HCV Treatment in Older Adults

By

DAA therapy is highly efficacious for the treatment of HCV infection in individuals >65 years old.

More Articles by Virginia Schad, PharmD

Sign Up for Free e-newsletters